PNC Financial Services Group Inc. Sells 1,530 Shares of Integer Holdings Co. (NYSE:ITGR)

PNC Financial Services Group Inc. reduced its position in shares of Integer Holdings Co. (NYSE:ITGR) by 32.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,243 shares of the medical equipment provider’s stock after selling 1,530 shares during the period. PNC Financial Services Group Inc.’s holdings in Integer were worth $430,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Mather Group LLC. increased its position in Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 143 shares during the period. R Squared Ltd bought a new stake in shares of Integer in the fourth quarter worth $44,000. Versant Capital Management Inc increased its holdings in Integer by 98.4% in the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after purchasing an additional 183 shares during the period. Principal Securities Inc. raised its position in Integer by 31.2% during the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 152 shares during the last quarter. Finally, Contravisory Investment Management Inc. lifted its holdings in Integer by 210.8% during the 4th quarter. Contravisory Investment Management Inc. now owns 693 shares of the medical equipment provider’s stock worth $92,000 after buying an additional 470 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on the company. KeyCorp increased their target price on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Oppenheimer cut shares of Integer from an “outperform” rating to a “market perform” rating in a research report on Friday, February 21st. Citigroup boosted their target price on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a report on Wednesday, December 11th. Truist Financial increased their price target on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Finally, Wells Fargo & Company reissued an “overweight” rating and issued a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Integer presently has an average rating of “Moderate Buy” and a consensus target price of $149.00.

Integer Trading Down 3.8 %

Shares of ITGR stock opened at $116.12 on Friday. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The firm has a market cap of $3.90 billion, a P/E ratio of 34.56, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24. The business has a 50-day moving average price of $132.96 and a two-hundred day moving average price of $132.42. Integer Holdings Co. has a 12-month low of $107.11 and a 12-month high of $146.36.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The company had revenue of $449.50 million for the quarter, compared to the consensus estimate of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Equities analysts anticipate that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.